Search research articles
Contact Us
Filters
Showing results (331-340 of 360) with videos related to
Page
of 36
Sort By:
The British Journal of Dermatology
|
April 7, 2021
Topical preparations for the treatment of mild-to-moderate acne vulgaris: systematic review and network meta-analysis
B Stuart, E Maund, C Wilcox, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 24, 2013
Control of cell proliferation, endoreduplication, cell size, and cell death by the retinoblastoma-related pathway in maize endosperm
Paolo A Sabelli, Yan Liu, Ricardo A Dante, et al.
Dermatology (Basel, Switzerland)
|
January 1, 1997
Roaccutane treatment guidelines: results of an international survey
W J Cunliffe, P C van de Kerkhof, R Caputo, et al.
Wellcome Open Research
|
October 25, 2021
A clinical study to optimise a sand fly biting protocol for use in a controlled human infection model of cutaneous leishmaniasis (the FLYBITE study)
Vivak Parkash, Helen Ashwin, Jovana Sadlova, et al.
JAMA
|
June 15, 1999
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense
D A Henderson, T V Inglesby, J G Bartlett, et al.
Nature Medicine
|
August 2, 2024
Safety and reactogenicity of a controlled human infection model of sand fly-transmitted cutaneous leishmaniasis
Vivak Parkash, Helen Ashwin, Shoumit Dey, et al.
Human Genetics
|
April 4, 2000
Molecular analysis of the genotype-phenotype relationship in factor X deficiency
D S Millar, L Elliston, P Deex, et al.
Health Technology Assessment (Winchester, England)
|
September 13, 2024
Clinical and cost-effectiveness of spironolactone in treating persistent facial acne in women: SAFA double-blinded RCT
Miriam Santer, Megan Lawrence, Sarah Pyne, et al.
BMJ Open
|
August 27, 2021
Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult women
Susanne Renz, Fay Chinnery, Beth Stuart, et al.
BMJ (Clinical Research Ed.)
|
May 16, 2023
Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial
Miriam Santer, Megan Lawrence, Susanne Renz, et al.
Page
of 36
Search research articles
Search
Showing results (331-340 of 360) with videos related to
Sort By:
Page
of 36
The British Journal of Dermatology
|
April 7, 2021
Topical preparations for the treatment of mild-to-moderate acne vulgaris: systematic review and network meta-analysis
B Stuart, E Maund, C Wilcox, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 24, 2013
Control of cell proliferation, endoreduplication, cell size, and cell death by the retinoblastoma-related pathway in maize endosperm
Paolo A Sabelli, Yan Liu, Ricardo A Dante, et al.
Dermatology (Basel, Switzerland)
|
January 1, 1997
Roaccutane treatment guidelines: results of an international survey
W J Cunliffe, P C van de Kerkhof, R Caputo, et al.
Wellcome Open Research
|
October 25, 2021
A clinical study to optimise a sand fly biting protocol for use in a controlled human infection model of cutaneous leishmaniasis (the FLYBITE study)
Vivak Parkash, Helen Ashwin, Jovana Sadlova, et al.
JAMA
|
June 15, 1999
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense
D A Henderson, T V Inglesby, J G Bartlett, et al.
Nature Medicine
|
August 2, 2024
Safety and reactogenicity of a controlled human infection model of sand fly-transmitted cutaneous leishmaniasis
Vivak Parkash, Helen Ashwin, Shoumit Dey, et al.
Human Genetics
|
April 4, 2000
Molecular analysis of the genotype-phenotype relationship in factor X deficiency
D S Millar, L Elliston, P Deex, et al.
Health Technology Assessment (Winchester, England)
|
September 13, 2024
Clinical and cost-effectiveness of spironolactone in treating persistent facial acne in women: SAFA double-blinded RCT
Miriam Santer, Megan Lawrence, Sarah Pyne, et al.
BMJ Open
|
August 27, 2021
Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult women
Susanne Renz, Fay Chinnery, Beth Stuart, et al.
BMJ (Clinical Research Ed.)
|
May 16, 2023
Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial
Miriam Santer, Megan Lawrence, Susanne Renz, et al.
Page
of 36